The use of mycophenolate mofetil in the treatment of refractory chronic graft versus host disease.

被引:0
|
作者
Pallotta, RS
Barbosa, JAL
Macedo, MCMA
Saboya, R
Silva, RL
Jamra, M
Chamone, DAF
Dulley, FL
机构
[1] Hemoctr Sao Paulo, Fundacao Prosangue, BMT Program, Sao Paulo, Brazil
[2] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4489
引用
收藏
页码:346B / 346B
页数:1
相关论文
共 50 条
  • [31] Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease.
    Neurath, MF
    Wanitschke, R
    Peters, M
    Krummenauer, F
    zum Büschenfelde, KHM
    Schlaak, JF
    GASTROENTEROLOGY, 1998, 114 (04) : A1050 - A1050
  • [32] Alemtuzumab in the treatment of steroid refractory acute Graft-versus-Host Disease.
    Gomez-Almaguer, David
    Ruiz-Arguelles, Guillermo
    Gonzalez-Llano, Oscar
    Cantu, Olga G.
    Gutierrez, Cesar H.
    Jaime-Perez, Jose Carlos
    Tarin-Arzaga, Luz
    Giralt, Sergio
    BLOOD, 2006, 108 (11) : 415B - 416B
  • [33] Mycophenolate mofetil for the management of steroid-refractory acute graft vs host disease
    J Pidala
    J Kim
    J Perkins
    T Field
    H Fernandez
    L Perez
    E Ayala
    M Kharfan-Dabaja
    C Anasetti
    Bone Marrow Transplantation, 2010, 45 : 919 - 924
  • [34] Mycophenolate mofetil for the management of steroid-refractory acute graft vs host disease
    Pidala, J.
    Kim, J.
    Perkins, J.
    Field, T.
    Fernandez, H.
    Perez, L.
    Ayala, E.
    Kharfan-Dabaja, M.
    Anasetti, C.
    BONE MARROW TRANSPLANTATION, 2010, 45 (05) : 919 - 924
  • [35] Extracorporeal photopheresis in the treatment of acute and chronic graft versus host disease.
    Salvaneschi, L
    Perotti, C
    Torretta, L
    Bernuzzi, S
    Viarengo, G
    Carbone, S
    Del Fante, C
    La Torre, R
    Locatelli, F
    BLOOD, 1999, 94 (10) : 378B - 378B
  • [36] Treatment of severe bone marrow (BM) graft versus host disease (GVHD) with mycophenolate mofetil (MMF)
    Correa, MR
    Leiva, L
    Ermitano, P
    Moore, C
    Sorensen, R
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (02) : S297 - S297
  • [37] THE USE OF MYCOPHENOLATE MOFETIL IN THE TREATMENT OF CHRONIC REFRACTORY IMMUNE THROMBOCYTOPENIA PURPURA
    Taylor, A.
    Neave, L.
    McGuckin, S.
    Terrinoni, I.
    Westwood, J.
    Cooper, N.
    Scully, M.
    HAEMATOLOGICA, 2013, 98 : 428 - 429
  • [38] Immunotherapy in the treatment of severe refractory chronic graft versus host disease
    Elez, M.
    Tarabar, O.
    Mirosavljevic, S.
    Balint, B.
    Radic, O. Tasic
    Skuletic, V.
    Marjanovic, S.
    Malesevic, M.
    Tukic, L.
    Stamatovic, D.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S578 - S579
  • [39] The use of mycophenolate mofetil in the treatment of chronic refractory immune thrombocytopenia purpura
    Taylor, A. M.
    Cooper, N.
    Neave, E. L.
    Westwood, J. P.
    McGuckin, S.
    Terrinoni, I.
    Scully, M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 : 10 - 11
  • [40] Response to thalidomide therapy in patients with refractory chronic graft-versus-host disease.
    Browne, PV
    Wagner, J
    Weisdorf, DJ
    DeFor, T
    Miller, WJ
    Davies, SM
    Filipovich, A
    McGlave, PB
    Ramsay, NKC
    Enright, H
    BLOOD, 1995, 86 (10) : 1577 - 1577